Esco Ventures

What is Esco Ventures?

Esco Ventures, based in Singapore, is a corporate venture capital fund specializing in seed-stage investments primarily in the life sciences and healthcare sectors. They have strategically positioned themselves in key global hubs such as Singapore and Shanghai, optimizing their reach and influence within the life sciences ecosystem.

Esco Ventures employs a targeted approach to investment, with a focus on groundbreaking science that promises to reshape the healthcare landscape. As a firm, they actively seek out and foster innovation by supporting visionary entrepreneurs and pioneering technologies that have the potential for substantial impact. They are committed to supporting the growth of their portfolio companies that offer novel therapeutics for conditions such as immunological diseases.

By investing in early-stage ventures, Esco Ventures aims to propel these transformative technologies to success and create a lasting global impact. Their active portfolio illustrates a commitment to investing in and nurturing companies that are working on life-changing science. The firm also emphasizes the importance of cross-border ecosystems, and leverages its global networks to drive innovation and collaboration in the life sciences sector.

Their recent highlights include welcoming Prof. Harvey Lodish as Chair of the Scientific Advisory Board for Carcell Biopharma and the announcement of a Series A funding round for Carmine Therapeutics.

Esco Ventures encourages collaboration with leading scientists and innovators to discover new ideas, develop technologies, and accelerate the translation of scientific advances into positive impacts on society.